MDMB-CHMICA
Overview[edit]
MDMB-CHMICA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors and is often found in products marketed as "spice" or "synthetic marijuana." MDMB-CHMICA is known for its high potency and potential for adverse effects.
Chemical Structure[edit]
MDMB-CHMICA is chemically classified as an indole-3-carboxamide. Its full chemical name is methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate. The structure includes a cyclohexylmethyl group attached to the indole core, which is a common feature in many synthetic cannabinoids.
Pharmacology[edit]
MDMB-CHMICA acts as a full agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation. The high affinity and efficacy of MDMB-CHMICA at these receptors contribute to its potent psychoactive effects.
Effects and Toxicity[edit]
The effects of MDMB-CHMICA can include euphoria, altered perception, and relaxation, similar to those of THC, the active component of cannabis. However, due to its high potency, MDMB-CHMICA can also cause severe adverse effects such as tachycardia, hypertension, nausea, vomiting, anxiety, paranoia, and hallucinations. In some cases, it has been associated with seizures and acute kidney injury.
Legal Status[edit]
Due to its potential for abuse and adverse health effects, MDMB-CHMICA has been classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and other new psychoactive substances.
